353 related articles for article (PubMed ID: 15488757)
1. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis.
Cao R; Björndahl MA; Religa P; Clasper S; Garvin S; Galter D; Meister B; Ikomi F; Tritsaris K; Dissing S; Ohhashi T; Jackson DG; Cao Y
Cancer Cell; 2004 Oct; 6(4):333-45. PubMed ID: 15488757
[TBL] [Abstract][Full Text] [Related]
2. Vascular frontiers without borders: multifaceted roles of platelet-derived growth factor (PDGF) in supporting postnatal angiogenesis and lymphangiogenesis.
Vincent L; Rafii S
Cancer Cell; 2004 Oct; 6(4):307-9. PubMed ID: 15488752
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of platelet-derived growth factor-BB expression in human esophageal squamous cell carcinomas.
Matsumoto S; Yamada Y; Narikiyo M; Ueno M; Tamaki H; Miki K; Wakatsuki K; Enomoto K; Yokotani T; Nakajima Y
Anticancer Res; 2007; 27(4B):2409-14. PubMed ID: 17695532
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor (PDGF)-BB produces NO-mediated relaxation and PDGF receptor β-dependent tonic contraction in murine iliac lymph vessels.
Maejima D; Kawai Y; Ajima K; Ohhashi T
Microcirculation; 2011 Aug; 18(6):474-86. PubMed ID: 21535294
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancer.
Liu J; Liu C; Qiu L; Li J; Zhang P; Sun Y
Diagn Pathol; 2014 Jun; 9():128. PubMed ID: 24972450
[TBL] [Abstract][Full Text] [Related]
7. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
8. Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis.
Cao Y
Cell Cycle; 2005 Feb; 4(2):228-30. PubMed ID: 15655347
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3.
Kanaki T; Bujo H; Mori S; Yanjuan Z; Takahashi K; Yokote K; Morisaki N; Saito Y
Biochem Biophys Res Commun; 2002 Jun; 294(2):231-7. PubMed ID: 12051699
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.
Lederle W; Stark HJ; Skobe M; Fusenig NE; Mueller MM
Am J Pathol; 2006 Nov; 169(5):1767-83. PubMed ID: 17071599
[TBL] [Abstract][Full Text] [Related]
11. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
12. VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.
Onimaru M; Yonemitsu Y; Fujii T; Tanii M; Nakano T; Nakagawa K; Kohno R; Hasegawa M; Nishikawa S; Sueishi K
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1685-96. PubMed ID: 19734356
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis.
Björndahl MA; Cao R; Burton JB; Brakenhielm E; Religa P; Galter D; Wu L; Cao Y
Cancer Res; 2005 Oct; 65(20):9261-8. PubMed ID: 16230387
[TBL] [Abstract][Full Text] [Related]
14. Embryonic mouse testis development: role of platelet derived growth factor (PDGF-BB).
Ricci G; Catizone A; Galdieri M
J Cell Physiol; 2004 Sep; 200(3):458-67. PubMed ID: 15254974
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors.
Watanabe S; Matsuda A; Suzuki Y; Kondo K; Ikeda Y; Hashimoto H; Umemura K
Br J Pharmacol; 2000 May; 130(2):307-14. PubMed ID: 10807667
[TBL] [Abstract][Full Text] [Related]
16. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
[TBL] [Abstract][Full Text] [Related]
17. Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.
Hansen K; Johnell M; Siegbahn A; Rorsman C; Engström U; Wernstedt C; Heldin CH; Rönnstrand L
EMBO J; 1996 Oct; 15(19):5299-313. PubMed ID: 8895575
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
19. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.
Hirakawa S; Kodama S; Kunstfeld R; Kajiya K; Brown LF; Detmar M
J Exp Med; 2005 Apr; 201(7):1089-99. PubMed ID: 15809353
[TBL] [Abstract][Full Text] [Related]
20. Expression of platelet-derived growth factor receptor β is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis.
Miyazaki H; Yoshimatsu Y; Akatsu Y; Mishima K; Fukayama M; Watabe T; Miyazono K
Cancer Sci; 2014 Sep; 105(9):1116-23. PubMed ID: 24981766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
